Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADAR-Canada: Active Deresuscitation in ICU
NCT06326112Phase 2Not yet recruiting
- Sponsor
- Unity Health Toronto
- Start
- May 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in Fluid overload, sponsored by Unity Health Toronto. Planned start May 2024; status: not yet recruiting.
02
Drugs
furosemide
03
Conditions
Fluid overload
Beyond the preview
Go deeper on NCT06326112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06326112.